SYENSQO financials
SYENSQO
549300060XNJ90PLNS10 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €6.85B | €7.07B |
| Cost of sales | €4.63B | €4.69B |
| Gross profit | €2.22B | €2.38B |
| Administrative expenses | €697.0M | €521.0M |
| Operating profit (EBIT) | €471.0M | €547.0M |
| Profit before tax | €352.0M | €389.0M |
| Income tax expense | €357.0M | €192.0M |
| Profit for the year | -€5.0M | €197.0M |
| — attributable to owners | -€5.0M | €193.0M |
| — attributable to NCI | €0 | €3.0M |
| Total comprehensive income | €163.0M | -€41.0M |
| Per share | ||
| Basic EPS | €-0.05 | €1.83 |
| Diluted EPS | €-0.05 | €1.82 |
| Free cash flow / share | €3.32 | €4.74 |
| Cash flow statement | ||
| Net cash from operating activities | €841.0M | €1.27B |
| Net cash from investing activities | -€612.0M | -€1.23B |
| Purchase of PP&E (capex) | €509.0M | €762.0M |
| Purchase of intangibles | €115.0M | €88.0M |
| Net cash from financing activities | -€723.0M | €890.0M |
| Dividends paid | €173.0M | €8.0M |
| Proceeds from borrowings | €1.31B | €1.75B |
| Repayments of borrowings | €1.57B | €3.21B |
| Lease liability payments | €61.0M | €53.0M |
| Net change in cash | -€493.0M | €934.0M |
| Balance sheet | ||
| Total assets | €12.37B | €12.89B |
| Non-current assets | €9.08B | €9.11B |
| Property, plant & equipment | €3.73B | €3.49B |
| Right-of-use assets | €188.0M | €188.0M |
| Intangible assets & goodwill | €2.66B | €2.56B |
| Current assets | €3.29B | €3.79B |
| Inventories | €1.27B | €1.24B |
| Trade & other receivables | €948.0M | €907.0M |
| Cash & equivalents | €659.0M | €1.15B |
| Total equity | €7.48B | €7.61B |
| Non-controlling interests | €50.0M | €42.0M |
| Non-current liabilities | €2.96B | €3.44B |
| Current liabilities | €1.93B | €1.84B |
| Deferred tax liabilities | €381.0M | €428.0M |
| Derived metrics | ||
| Free cash flow | €332.0M | €513.0M |
| Operating margin | 6.9% | 7.7% |
| Net margin | -0.1% | 2.8% |
| Return on equity | -0.1% | 2.6% |
| Cash conversion ratio | -168.20× | 6.47× |
| Capex coverage | 1.65× | 1.67× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €732.0M | €739.0M |
| Adjustments For Finance Income Cost | -€119.0M | -€158.0M |
| Adjustments For Income Tax Expense | €357.0M | €192.0M |
| Adjustments For Provisions | €84.0M | €470.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €21.0M | €25.0M |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | €1.28B | €1.47B |
| Cancellation of Treasury Shares | €0 | — |
| Cash Advances and Loans From Related Parties | €0 | €771.0M |
| Cash Advances and Loans Made To Related Parties | €5.0M | €0 |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €4.0M | €2.0M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €0 | €172.0M |
| Cash Repayments of Advances and Loans From Related Parties | €0 | €2.27B |
| Comprehensive Income Attributable To Noncontrolling Interests | €2.0M | €1.0M |
| Comprehensive Income Attributable To Owners of Parent | €161.0M | -€42.0M |
| Current Tax Assets Current | €51.0M | €52.0M |
| Current Tax Liabilities Current | €25.0M | €58.0M |
| Deferred Tax Assets | €391.0M | €661.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €170.0M | €0 |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €168.0M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €1.62 | — |
| Dividends Received Classified As Investing Activities | €2.0M | €1.0M |
| Dividends Received Classified As Operating Activities | €20.0M | €6.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €2.0M | -€28.0M |
| Equity and Liabilities | €12.37B | €12.89B |
| Equity Instruments Held | €86.0M | €94.0M |
| Expense Due To Unwinding of Discount On Provisions | €18.0M | €28.0M |
| Gains Losses On Cash Flow Hedges Before Tax | €40.0M | -€50.0M |
| Gains Losses On Exchange Differences On Translation Before Tax | €213.0M | -€169.0M |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -€7.0M | €10.0M |
| Income Tax Relating To Components of Other Comprehensive Income | €10.0M | -€28.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €181.0M | €288.0M |
| Increase Decrease In Working Capital | €123.0M | -€108.0M |
| Increase Decrease Through Other Contributions By Owners | €9.0M | €7.0M |
| Increase Decrease Through Sharebased Payment Transactions | €19.0M | €11.0M |
| Increase Decrease Through Transfers and Other Changes Equity | €6.0M | — |
| Increase Decrease Through Treasury Share Transactions | -€137.0M | €2.0M |
| Intangible Assets Other Than Goodwill | €1.64B | €1.66B |
| Interest Expense | €113.0M | €190.0M |
| Investment Accounted For Using Equity Method | €208.0M | €207.0M |
| Issue of Equity | — | €0 |
| Issued Capital | €1.35B | €1.35B |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €13.0M | €19.0M |
| Noncurrent Portion of Other Noncurrent Borrowings | €1.82B | €2.16B |
| Noncurrent Provisions For Employee Benefits | €395.0M | €373.0M |
| Other Adjustments For Noncash Items | €7.0M | -€62.0M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €3.0M | €14.0M |
| Other Comprehensive Income | €168.0M | -€238.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | -€3.0M | -€6.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€78.0M | -€35.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | €260.0M | -€225.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Before Tax | -€81.0M | -€41.0M |
| Other Current Borrowings and Current Portion of Other Noncurrent Borrowings | €293.0M | €154.0M |
| Other Current Financial Assets | €67.0M | €48.0M |
| Other Current Liabilities | €392.0M | €417.0M |
| Other Current Receivables | €297.0M | €385.0M |
| Other Finance Income Cost | -€4.0M | -€31.0M |
| Other Gains Losses | -€161.0M | -€141.0M |
| Other Inflows Outflows of Cash Classified As Financing Activities | €0 | -€9.0M |
| Other Longterm Provisions | €314.0M | €405.0M |
| Other Noncurrent Financial Assets | €30.0M | €30.0M |
| Other Noncurrent Liabilities | €50.0M | €76.0M |
| Other Shortterm Provisions | €219.0M | €297.0M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €9.0M | €1.0M |
| Proceeds From Issuing Other Equity Instruments | €9.0M | €7.0M |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €624.0M | €850.0M |
| Research and Development Expense | €342.0M | €339.0M |
| Revenue From Interest | €22.0M | €81.0M |
| Sales and Marketing Expense | €308.0M | €296.0M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Before Tax | €6.0M | -€6.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €21.0M | €25.0M |
| Share Premium | €1.02B | €1.02B |
| Trade and Other Current Payables To Trade Suppliers | €1.00B | €918.0M |
Every line item above is a fact tagged in SYENSQO's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.